Article Information
History
- May 19, 2020.
Article Versions
- Version 1 (May 5, 2020 - 04:30).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- D. De Smet, MD1,
- K. De Smet, MD2,
- P. Herroelen, MSc.1,
- S. Gryspeerdt, MD2 and
- G.A. Martens, MD, PhD1,3,*
- 1AZ Delta Medical Laboratories, Roeselare, Belgium
- 2Department of Radiology, AZ Delta General Hospital, Roeselare, Belgium
- 3VUB Metabolomics Platform, Brussels Free University
- ↵*Corresponding author: Geert A. Martens, AZ Delta Medical Laboratories, AZ Delta General Hospital, Deltalaan 1, 8800 Roeselare. Tel:+32 51 23 71 96 Email: geert.martens{at}azdelta.be, medRxiv doi: https://doi.org/10.1101/2020.05.01.20079376
Trial registration: Clinical Trial Number IRB B1172020000009
Posted May 19, 2020.
Vitamin D deficiency as risk factor for severe COVID-19: a convergence of two pandemics
